PCM
AEHR icon

Portolan Capital Management’s Aehr Test Systems AEHR Stock Holding History

Portolan Capital Management’s Portfolio AEHR Stock Details AEHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-68,191
Closed -$1.37M – 141
2022
Q4 		$1.37M Buy
+68,191
New +$1.46M 0.14% 121

Other funds holding AEHR

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Portolan Capital Management's AEHR Position: Q1 2023 in Review

Portolan Capital Management sold out of Aehr Test Systems (AEHR) in Q1 2023, closing a stake of 68,191 shares — an estimated $1.37M sold.

Portolan Capital Management first reported a position in AEHR in Q4 2022 and held it in 1 quarter. The position peaked at $1.37M in Q4 2022. 144 funds tracked by Wall St. Rank hold AEHR as of Q1 2023.

  • Portolan Capital Management reported no remaining Aehr Test Systems position as of Q1 2023 after selling out during the quarter.
  • Portolan Capital Management sold 68,191 Aehr Test Systems shares in Q1 2023, an estimated $1.37M.
  • Portolan Capital Management first reported a position in Aehr Test Systems in Q4 2022 and held it in 1 quarter.
  • Portolan Capital Management's Aehr Test Systems position peaked at $1.37M in Q4 2022.
  • 144 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2023.

Based on Portolan Capital Management's 13F filing for Q1 2023, filed 15 May 2023.